Irodalom:
1. Targan SR, Hanauer SB, van Deventer SJ et al: A short term study of chimeric monoclonal antibody
cA2 to tumor necrosis factor alpha for Crohn’s disease. N. Eng. J Med 1997; 337.: 1029-1035
2. Hanauer SB, Feagan BG, Lichtenstein GR et al: Maintance infliximab for Crohn’s disease: the
ACCENT I randomised trial. Lancet 2002; 359: 1541-1549
3. Shoenut JP Semelka RC: Magnetic resonanc imaging in inflammatory bowel disease. J Clin.
Gastroenterpl 1993; 17:73-78
4. Schunk K, Kern A, Oberholzer K: Hydro-MRI in Crohn’s disease: appriasal of disease activity. Invest
Radiol 2000; 35:431-437
5. Pauls S, Kratzer W, Rieber A.: Quantifying the inflammatory activity in Crohn’s disease using CE
dynamic MRI Rofo Fortschr. Geb. Rontgenstr Neuen Bildgeb Verfahr 2003;175:1093-1099.
